Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…
Your Compass for Current News
